• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者的心血管疾病负担。

Burden of cardiovascular disease in chronic obstructive pulmonary disease.

机构信息

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Department of Pulmonary and Critical Care Medicine, Cleveland Clinic, Cleveland, Ohio.

出版信息

Am J Prev Med. 2014 Aug;47(2):105-14. doi: 10.1016/j.amepre.2014.03.014. Epub 2014 Jul 3.

DOI:10.1016/j.amepre.2014.03.014
PMID:24997571
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) and atherosclerotic vascular disease share several etiopathogenic factors.

PURPOSE

To compare the prevalence of self-reported cardiovascular and cerebrovascular disease (CCVD) between COPD and non-COPD subjects using the National Health and Nutrition Examination Survey (NHANES) database. Among subjects without pre-existent CCVD, the short-term and lifetime risks of future CCVD were also compared between the two groups.

METHODS

Pooled NHANES 2007-2010 data were analyzed in May 2012 and April 2013. Based on predicted Framingham risk, subjects without self-reported CCVD were classified as follows: high short-term risk, low short-term/high lifetime risk, and low short-term/low lifetime risk for future CCVD.

RESULTS

Estimated self-reported CCVD prevalence was 20.0% and 7.4% in COPD and non-COPD groups, respectively (p<0.001). On multivariable analysis, COPD was an independent risk factor for prevalent self-reported CCVD (prevalence ratio=1.4, 95% CI=1.1, 1.8). Among subjects without CCVD, there were significant differences in predicted future CCVD risk between the two groups. In the non-COPD group, prevalence of high short-term risk, low short-term/high lifetime risk, and low short-term/low lifetime risk was 18.9%, 62.7%, and 18.4%, respectively. In the COPD group, corresponding prevalence estimates were 35.8%, 53.2%, and 11.1%, respectively. Men and women had significantly different risk factor profiles for future CCVD.

CONCLUSIONS

The prevalence of self-reported CCVD was significantly higher in subjects with COPD than in those without COPD. Among subjects without pre-existent CCVD, the risk of future CCVD was significantly higher in the COPD group than in the non-COPD group.

摘要

背景

慢性阻塞性肺疾病(COPD)和动脉粥样硬化性血管疾病有几个共同的发病因素。

目的

利用国家健康和营养调查(NHANES)数据库比较 COPD 和非 COPD 患者报告的心血管和脑血管疾病(CCVD)的患病率。在无预先存在的 CCVD 的患者中,还比较了两组之间未来 CCVD 的短期和终生风险。

方法

2012 年 5 月和 2013 年 4 月分析了 2007-2010 年 NHANES 合并数据。根据预测的弗雷明汉风险,将无自我报告 CCVD 的患者分为以下几类:短期风险高、短期风险低但终生风险高、短期风险低且终生风险低。

结果

COPD 和非 COPD 组的自我报告 CCVD 患病率分别为 20.0%和 7.4%(p<0.001)。多变量分析显示,COPD 是自我报告 CCVD 的独立危险因素(患病率比=1.4,95%CI=1.1,1.8)。在无 CCVD 的患者中,两组之间未来 CCVD 风险存在显著差异。在非 COPD 组中,短期风险高、短期风险低但终生风险高和短期风险低且终生风险低的患病率分别为 18.9%、62.7%和 18.4%。在 COPD 组中,相应的患病率估计分别为 35.8%、53.2%和 11.1%。男性和女性未来 CCVD 的危险因素分布存在显著差异。

结论

与非 COPD 患者相比,COPD 患者自我报告 CCVD 的患病率显著更高。在无预先存在的 CCVD 的患者中,COPD 组未来 CCVD 的风险明显高于非 COPD 组。

相似文献

1
Burden of cardiovascular disease in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的心血管疾病负担。
Am J Prev Med. 2014 Aug;47(2):105-14. doi: 10.1016/j.amepre.2014.03.014. Epub 2014 Jul 3.
2
Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease.慢性阻塞性肺疾病临床前阶段的危险因素和合并症。
Am J Respir Crit Care Med. 2014 Jan 1;189(1):30-8. doi: 10.1164/rccm.201307-1240OC.
3
Heavy metals and cardiovascular disease: results from the National Health and Nutrition Examination Survey (NHANES) 1999-2006.重金属与心血管疾病:来自 1999-2006 年全国健康与营养调查(NHANES)的结果。
Angiology. 2011 Jul;62(5):422-9. doi: 10.1177/0003319710395562. Epub 2011 Mar 18.
4
The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.瑞典乌普萨拉慢性阻塞性肺疾病的患病率——慢性阻塞性肺病负担(BOLD)研究:基于人群的横断面研究
Clin Respir J. 2012 Apr;6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x. Epub 2011 Jul 6.
5
Gender and chronic obstructive pulmonary disease in high-risk smokers.高危吸烟者中的性别与慢性阻塞性肺疾病
Respiration. 2006;73(3):306-10. doi: 10.1159/000090051. Epub 2005 Nov 29.
6
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.加拿大萨斯喀彻温省慢性阻塞性肺疾病患者的心血管疾病,慢性阻塞性肺疾病患者的心血管疾病
Ann Epidemiol. 2006 Jan;16(1):63-70. doi: 10.1016/j.annepidem.2005.04.008. Epub 2005 Jul 21.
7
Prevalence of physical disability in patients with chronic obstructive pulmonary disease and associated risk factors.慢性阻塞性肺疾病患者身体残疾的流行情况及相关危险因素。
COPD. 2013 Oct;10(5):611-7. doi: 10.3109/15412555.2013.781150. Epub 2013 Jul 11.
8
Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.高收入和低收入国家慢性阻塞性肺疾病的全球负担。第一部分。阻塞性肺病负担(BOLD)倡议。
Int J Tuberc Lung Dis. 2008 Jul;12(7):703-8.
9
Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.葡萄牙里斯本慢性阻塞性肺疾病患病率:阻塞性肺病负担研究
Rev Port Pneumol. 2013 May-Jun;19(3):96-105. doi: 10.1016/j.rppneu.2012.11.004. Epub 2013 May 8.
10
Distribution of short and lifetime risks for cardiovascular disease in Italians.意大利人心血管疾病短期和终生风险分布。
Eur J Prev Cardiol. 2012 Aug;19(4):723-30. doi: 10.1177/1741826711410820. Epub 2011 May 13.

引用本文的文献

1
The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among United States adults with COPD: results from NHANES 1999-2018.中性粒细胞与淋巴细胞比值可预测美国慢性阻塞性肺疾病(COPD)成人患者的全因死亡率和心血管死亡率:1999 - 2018年美国国家健康与营养检查调查(NHANES)结果
Front Med (Lausanne). 2024 Sep 25;11:1443749. doi: 10.3389/fmed.2024.1443749. eCollection 2024.
2
Effect of chronic lung diseases on angina pectoris among Indian adults: longitudinal ageing study in India.慢性肺部疾病对印度成年人心绞痛的影响:印度纵向老龄化研究。
Sci Rep. 2024 Jan 29;14(1):2372. doi: 10.1038/s41598-024-52786-x.
3
Optimizing inhaled corticosteroid use in patients with chronic obstructive pulmonary disease: assessing blood eosinophils, neutrophil-to-lymphocyte ratio, and mortality outcomes in US adults.
优化慢性阻塞性肺疾病患者吸入性皮质类固醇的使用:评估美国成年人血液嗜酸性粒细胞、中性粒细胞与淋巴细胞比值和死亡率结局。
Front Immunol. 2023 Nov 15;14:1230766. doi: 10.3389/fimmu.2023.1230766. eCollection 2023.
4
Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy.慢性阻塞性肺疾病中的心血管疾病:从诊断、患病率到治疗
Life (Basel). 2023 May 31;13(6):1299. doi: 10.3390/life13061299.
5
Impact of Cardiovascular and Metabolic Comorbidities on Long-term Outcomes of Home-based Pulmonary Rehabilitation in COPD.心血管和代谢合并症对 COPD 患者家庭肺康复长期结局的影响。
Int J Chron Obstruct Pulmon Dis. 2023 Feb 23;18:155-167. doi: 10.2147/COPD.S381744. eCollection 2023.
6
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: results on cardiovascular safety from the IMPACT trial.在 COPD 患者中,氟替卡松富马酸酯/乌美溴铵/维兰特罗单吸入器三联疗法与氟替卡松富马酸酯/维兰特罗和乌美溴铵/维兰特罗的比较:IMPACT 试验心血管安全性结果。
Respir Res. 2020 Jun 5;21(1):139. doi: 10.1186/s12931-020-01398-w.
7
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).慢性阻塞性肺疾病患者心血管疾病一级预防中的抗血小板治疗:一项随机对照概念验证试验的方案 (APPLE COPD-ICON 2)。
BMJ Open. 2018 May 26;8(5):e020713. doi: 10.1136/bmjopen-2017-020713.
8
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.慢性阻塞性肺疾病患者的血浆生长分化因子15水平与亚临床冠状动脉疾病相关。
Respir Res. 2017 Feb 28;18(1):42. doi: 10.1186/s12931-017-0521-1.
9
Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study.“年龄、基因、环境与易感性研究(AGES Reykjavik study)”中的气流阻塞、动脉粥样硬化与心血管危险因素
Atherosclerosis. 2016 Sep;252:122-127. doi: 10.1016/j.atherosclerosis.2016.07.919. Epub 2016 Jul 28.
10
Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease.慢性肾脏病和慢性阻塞性肺疾病患者的死亡率结局
Am J Nephrol. 2016;43(1):39-46. doi: 10.1159/000444422. Epub 2016 Feb 19.